Innovative Pharmaceutical Biotech Limited
HKEX:0399.HK
0.204 (HKD) • At close November 1, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 6.593 | 8.075 | 11.145 | 15.189 | 14.58 | 18.589 | 15.811 | 9.187 | 19.908 | 33.976 | 36.185 | 10.05 | 25.475 | 90.193 | 483.947 | 374.442 | 317.041 | 83.111 | 32.028 | 29.061 | 29.092 |
| Cost of Revenue
| 5.753 | 7.217 | 10.091 | 13.784 | 12.96 | 16.842 | 14.416 | 8.46 | 19.319 | 33.058 | 36.997 | 18.059 | 10.437 | 56.686 | 442.967 | 362.895 | 308.933 | 78.817 | 27.821 | 25.618 | 26.535 |
| Gross Profit
| 0.84 | 0.858 | 1.054 | 1.405 | 1.62 | 1.747 | 1.395 | 0.727 | 0.589 | 0.918 | -0.813 | -8.009 | 15.038 | 33.507 | 40.98 | 11.547 | 8.108 | 4.294 | 4.207 | 3.443 | 2.557 |
| Gross Profit Ratio
| 0.127 | 0.106 | 0.095 | 0.093 | 0.111 | 0.094 | 0.088 | 0.079 | 0.03 | 0.027 | -0.022 | -0.797 | 0.59 | 0.372 | 0.085 | 0.031 | 0.026 | 0.052 | 0.131 | 0.118 | 0.088 |
| Reseach & Development Expenses
| 1.421 | 4.758 | 8.246 | 6.092 | 11.336 | 1.934 | 0.665 | 0.629 | 1.347 | 5.304 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 12.919 | 17.031 | 17.243 | 16.91 | 22.643 | 26.744 | 25.749 | 22.557 | 30.011 | 27.89 | 36.091 | 49.676 | 55.678 | 27.352 | 18.026 | 28.237 | 10.135 | 4.62 | 2.964 | 6.392 | 53.333 |
| Selling & Marketing Expenses
| -0.066 | 0 | 0 | 0 | 0 | 0 | 0 | 0.195 | 0.248 | 0 | 0.944 | 1.516 | 2.436 | 2.64 | 9.709 | 2.421 | 6.643 | 3.674 | 4.269 | 3.018 | 2.61 |
| SG&A
| 12.853 | 17.031 | 17.243 | 16.91 | 22.643 | 26.744 | 25.749 | 22.752 | 30.259 | 27.89 | 37.035 | 51.192 | 58.114 | 29.992 | 27.735 | 30.658 | 16.778 | 8.294 | 7.233 | 9.41 | 55.943 |
| Other Expenses
| 0.001 | 0.001 | 0.08 | -0.212 | 0.009 | 0 | 0.003 | 0.166 | -5.071 | -10.487 | 0 | -11.377 | -0.937 | 0.161 | -0.247 | -631.559 | -0.071 | -0.03 | -0.009 | -0.818 | -8.26 |
| Operating Expenses
| 14.274 | 21.561 | 25.489 | 22.79 | 33.979 | 28.678 | 26.414 | 23.381 | 31.606 | 33.194 | 570.51 | 51.192 | 57.177 | 24.812 | 27.488 | -600.901 | 16.707 | 8.264 | 7.224 | 8.592 | 47.683 |
| Operating Income
| -13.434 | -20.702 | -24.353 | -21.342 | -26.017 | -11.613 | -6.889 | -0.83 | -23.067 | -38.878 | -37.847 | -88.779 | -131.607 | 8.695 | 13.492 | 612.448 | -8.599 | -3.97 | -3.017 | -5.149 | -45.126 |
| Operating Income Ratio
| -2.038 | -2.564 | -2.185 | -1.405 | -1.784 | -0.625 | -0.436 | -0.09 | -1.159 | -1.144 | -1.046 | -8.834 | -5.166 | 0.096 | 0.028 | 1.636 | -0.027 | -0.048 | -0.094 | -0.177 | -1.551 |
| Total Other Income Expenses Net
| 112.141 | -233.969 | 60.784 | -190.813 | -196.445 | -249.298 | -224.102 | -177.512 | -209.93 | -424.638 | -533.955 | -0.938 | -95.745 | 0.161 | -0.184 | 133.883 | -59.947 | -60.457 | -49.936 | -35.848 | -1,411.488 |
| Income Before Tax
| 98.707 | -254.671 | 36.431 | -212.155 | -222.462 | -260.911 | -230.991 | -178.342 | -240.947 | -456.914 | -571.802 | -89.717 | -131.757 | 8.856 | 13.308 | 746.331 | -68.546 | -64.427 | -52.953 | -40.997 | -1,456.614 |
| Income Before Tax Ratio
| 14.971 | -31.538 | 3.269 | -13.968 | -15.258 | -14.036 | -14.61 | -19.412 | -12.103 | -13.448 | -15.802 | -8.927 | -5.172 | 0.098 | 0.027 | 1.993 | -0.216 | -0.775 | -1.653 | -1.411 | -50.069 |
| Income Tax Expense
| -4.696 | -8.973 | -260.107 | 183.597 | 185.1 | 116.966 | 113.434 | 60.924 | 142.181 | 360.348 | -2.502 | -0.06 | -2.06 | 3.25 | 2.132 | 1.09 | 0.033 | 0.01 | 49.936 | 35.848 | 1,411.488 |
| Net Income
| 103.403 | -245.698 | 296.538 | -395.752 | -407.562 | -260.272 | -231.048 | -169.788 | -236.865 | -451.684 | -569.301 | -72.839 | -123.882 | 5.247 | 11.262 | 745.205 | -68.621 | -64.052 | -52.953 | -40.997 | -1,456.614 |
| Net Income Ratio
| 15.684 | -30.427 | 26.607 | -26.055 | -27.953 | -14.001 | -14.613 | -18.481 | -11.898 | -13.294 | -15.733 | -7.248 | -4.863 | 0.058 | 0.023 | 1.99 | -0.216 | -0.771 | -1.653 | -1.411 | -50.069 |
| EPS
| 0.068 | -0.17 | 0.2 | -0.27 | -0.28 | -0.18 | -0.16 | -0.12 | -0.17 | -0.36 | -0.55 | -0.094 | -0.18 | 0.008 | 0.021 | 1.46 | -3.29 | -3.07 | -2.54 | -1.96 | -72.17 |
| EPS Diluted
| -0.008 | -0.17 | 0.17 | -0.27 | -0.28 | -0.18 | -0.16 | -0.12 | -0.17 | -0.36 | -0.55 | -0.094 | -0.18 | 0.008 | 0.021 | 1.46 | -3.29 | -3.07 | -2.54 | -1.96 | -72.17 |
| EBITDA
| -12.493 | -18.821 | -22.223 | -19.033 | -24.773 | -11.546 | -6.272 | 0.341 | -13.958 | -37.113 | -32.035 | -53.068 | 64.64 | 10.828 | 13.948 | 748.158 | -5.521 | -0.833 | -0.318 | -2.592 | -43.064 |
| EBITDA Ratio
| -1.895 | -2.331 | -1.994 | -1.253 | -1.699 | -0.621 | -0.397 | 0.037 | -0.701 | -1.092 | -0.885 | -5.28 | 2.537 | 0.12 | 0.029 | 1.998 | -0.017 | -0.01 | -0.01 | -0.089 | -1.48 |